The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics

E Pajarillo, A Rizor, J Lee, M Aschner, E Lee - Neuropharmacology, 2019 - Elsevier
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention

AL Sheldon, MB Robinson - Neurochemistry international, 2007 - Elsevier
Extracellular concentrations of the predominant excitatory neurotransmitter, glutamate, and
related excitatory amino acids are maintained at relatively low levels to ensure an …

Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

PM Beart, RD O'Shea - British journal of pharmacology, 2007 - Wiley Online Library
l‐Glutamate (Glu) is the major excitatory neurotransmitter in the mammalian CNS and five
types of high‐affinity Glu transporters (EAAT1–5) have been identified. The transporters …

Molecular physiology of preconditioning-induced brain tolerance to ischemia

TP Obrenovitch - Physiological reviews, 2008 - journals.physiology.org
Ischemic tolerance describes the adaptive biological response of cells and organs that is
initiated by preconditioning (ie, exposure to stressor of mild severity) and the associated …

Neuroprotective potential of ceftriaxone in in vitro models of stroke

J Lipski, CK Wan, JZ Bai, R Pi, D Li, D Donnelly - Neuroscience, 2007 - Elsevier
Astrocytic glutamate transporters are considered an important target for neuroprotective
therapies as the function of these transporters is abnormal in stroke and other neurological …

Glutamate transport and preterm brain injury

S Pregnolato, E Chakkarapani, AR Isles… - Frontiers in …, 2019 - frontiersin.org
Preterm birth complications are the leading cause of child death worldwide and a top global
health priority. Among the survivors, the risk of life-long disabilities is high, including cerebral …

GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes

E Lee, M Sidoryk-Wêgrzynowicz, N Wang… - Journal of Biological …, 2012 - ASBMB
The G protein-coupled estrogen receptor GPR30 contributes to the neuroprotective effects of
17β-estradiol (E2); however, the mechanisms associated with this protection have yet to be …

Intranasal administration of mesenchymal stem cell secretome reduces hippocampal oxidative stress, neuroinflammation and cell death, improving the behavioral …

N Farfán, J Carril, M Redel, M Zamorano… - International journal of …, 2020 - mdpi.com
Perinatal Asphyxia (PA) is a leading cause of motor and neuropsychiatric disability
associated with sustained oxidative stress, neuroinflammation, and cell death, affecting …

EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders

TL Lauriat, LA McInnes - Molecular psychiatry, 2007 - nature.com
The excitatory amino acid transporter 2 (EAAT2) is responsible for the majority of glutamate
uptake in the brain and its dysregulation has been associated with multiple psychiatric and …

Glutamate transporters in brain ischemia: to modulate or not?

W Krzyżanowska, B Pomierny, M Filip… - Acta Pharmacologica …, 2014 - nature.com
In this review, we briefly describe glutamate (Glu) metabolism and its specific transports and
receptors in the central nervous system (CNS). Thereafter, we focus on excitatory amino acid …